Zm. Hijazi et al., A NEW PLATINUM BALLOON-EXPANDABLE STENT (ANGIOSTENT(R)) MOUNTED ON A HIGH-PRESSURE BALLOON - ACUTE AND LATE RESULTS IN AN ATHEROGENIC SWINEMODEL, The Journal of invasive cardiology, 7(5), 1995, pp. 127-134
Background. Randomized studies have proven the efficacy and safety of
stent placement to treat de novo coronary stenosis. However, the poor
radio-opacity and the use of an additional high-pressure balloon to fu
lly expand the stent are the major limitations of the currently clinic
ally-approved stents. Objective. We evaluated the safety, efficacy, an
giographic and histologic effect of a new platinum balloon expandable
stent mounted on a high-pressure balloon in Yucatan miniature swine fe
d high cholesterol diet. Methods. Fifteen Angiostents(R) (NuMED, Inc.,
Hopkinton, NY and Angiodynamics, Glens Falls, NY) (coronary stent was
3, 3.5, or 4 mm in diameter and 12 mm long; renal and carotid stents
were 5 mm in diameter and 13 mm long) mounted on a high-pressure ballo
on were placed percutaneously in blood vessels of 10 pigs [5 in circum
flex (CX), 2 in left anterior descending (LAD), 5 in renal and 3 in ca
rotid arteries]. The stent was 10-20% larger than the native vessel di
ameter. All animals received 5000 I.U. of heparin during the procedure
and were maintained on 325 mg aspirin daily. Follow-up angiography an
d histology in the animals was performed at 2, 4, 12, 20, 26 and 52 we
eks. Results. The stents were easily visualized with fluoroscopy and p
laced in all animals without episodes of balloon rupture or embolizati
on. There was no episode of acute thrombosis. Follow-up angiography in
the animals revealed patency of all renal and carotid stents, however
, 2/7 coronary stents in the animals revealed angiographic lumen narro
wing (>20%) at 20 and 52 weeks. Histologic examination revealed neoint
imal formation at the stent site with an average neointimal thickness
ranging from 325-650 mu m. Conclusion. This stent was safe in this ani
mal model, easily deployed, had excellent radio-opacity and with good
short-term patency without anticoagulation. Clinical trials and experi
ence is underway.